12d36407e9742e064c0f6a706700f54f.jpg - Washington Times
Skip to content

FILE - The Commack, N.Y., branch of Forest Laboratories, a Manhattan-based pharmaceutical company, is seen in this Aug. 4, 2004, file photo. Actavis PLC plans to buy Forest Laboratories Inc. in an approximately $25 billion cash-and-stock combination that will create a drugmaker with a product portfolio that includes drugs like the Alzheimer's disease treatment Namenda. (AP Photo/Newsday, Jim Peppler, File)

FILE - The Commack, N.Y., branch of Forest Laboratories, a Manhattan-based pharmaceutical company, is seen in this Aug. 4, 2004, file photo. Actavis PLC plans to buy Forest Laboratories Inc. in an approximately $25 billion cash-and-stock combination that will create a drugmaker with a product portfolio that includes drugs like the Alzheimer's disease treatment Namenda. (AP Photo/Newsday, Jim Peppler, File)

Featured Photo Galleries

CounselGalleryCOVER.jpg

Special Counsels Rack Up Bills

Robert Mueller’s special counsel investigation into Russian meddling in the 2016 election has cost $6.7 million during the first four and a half months of the probe. Click to see past independent counsel investigations guilty of racking up high bills.